Torrent Pharmaceuticals Ltd.‘s Revenues for Q2 FY23 has increased by 7% YoY to ₹ 2,291 crores. Net Profit fell by 1% YoY to ₹ 312 crores. EBITDA fell by 2% YoY for Q2 FY 2023.
Net Profit fell to 13.6%. In this quarter’s press release, it is evident that there is a fall in revenue in Germany.
To further read about this company, check out this link.